Literature DB >> 16333134

Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods.

James E Ross, Ronald N Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333134      PMCID: PMC1317196          DOI: 10.1128/JCM.43.12.6212-6213.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  2 in total

1.  Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin.

Authors:  M A Pfaller; R N Jones; D H Walter
Journal:  Diagn Microbiol Infect Dis       Date:  2001 May-Jun       Impact factor: 2.803

2.  Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods.

Authors:  Ronald N Jones; Michael A Pfaller; Paul R Rhomberg; Donald H Walter
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

  2 in total
  6 in total

1.  Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.

Authors:  James E Ross; Helio S Sader; Zrinka Ivezic-Schoenfeld; Susanne Paukner; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

2.  Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.

Authors:  Ronald N Jones; Thomas R Fritsche; Helio S Sader; James E Ross
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

3.  Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.

Authors:  Glenn A Pankuch; Gengrong Lin; Dianne B Hoellman; Caryn E Good; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Unraveling the Metabolic Routes of Retapamulin: Insights into Drug Development of Pleuromutilins.

Authors:  Feifei Sun; Huiyan Zhang; Gerard Bryan Gonzales; Jinhui Zhou; Yi Li; Jinzhen Zhang; Yue Jin; Zhanhui Wang; Yanshen Li; Xingyuan Cao; Suxia Zhang; Shupeng Yang
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity.

Authors:  Chen Davidovich; Anat Bashan; Tamar Auerbach-Nevo; Rachel D Yaggie; Richard R Gontarek; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-08       Impact factor: 11.205

6.  Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.

Authors:  Maria M Traczewski; Steven D Brown
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.